ZA983669B - Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds. - Google Patents

Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds.

Info

Publication number
ZA983669B
ZA983669B ZA9803669A ZA983669A ZA983669B ZA 983669 B ZA983669 B ZA 983669B ZA 9803669 A ZA9803669 A ZA 9803669A ZA 983669 A ZA983669 A ZA 983669A ZA 983669 B ZA983669 B ZA 983669B
Authority
ZA
South Africa
Prior art keywords
quinazoline
methods
protein kinase
based compounds
threonine protein
Prior art date
Application number
ZA9803669A
Inventor
Peng Cho Tang
Gerald Mcmahon
Heinz Weinberger
Bernhard Kutscher
Harald App
Original Assignee
Sugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen Inc filed Critical Sugen Inc
Publication of ZA983669B publication Critical patent/ZA983669B/en

Links

ZA9803669A 1997-05-02 1998-04-30 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds. ZA983669B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4535197P 1997-05-02 1997-05-02

Publications (1)

Publication Number Publication Date
ZA983669B true ZA983669B (en) 1999-11-01

Family

ID=21937387

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9803669A ZA983669B (en) 1997-05-02 1998-04-30 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds.

Country Status (1)

Country Link
ZA (1) ZA983669B (en)

Similar Documents

Publication Publication Date Title
ZA988797B (en) Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds.
HK1031836A1 (en) Methods of modulating serine/threonine protein kinase function with 5-azaquinoxa-line-based compounds.
AU7282998A (en) Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds
ZA9810219B (en) Benzothiazole protein tyrosine kinase inhibitors.
AU3363599A (en) Heterocyclic families of compounds for the modulation of tyrosine protein kinase
AU5468499A (en) 3-methylidenyl-2-indolinone modulators of protein kinase
IL141866A0 (en) Pyrrolopyrimidines as protein kinase inhibitors
AU6411698A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU3693697A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
AU3766897A (en) Fused heterocyclic compounds as protein tyrosine kinase inhibitors
ZA991721B (en) Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors.
IL142828A0 (en) Short peptides which selectively modulate the activity of protein kinases
ZA9810332B (en) Aminothiazone inhibitors of cyclin dependent kinases.
AU8681798A (en) Imidazoquinoxaline protein tyrosine kinase inhibitors
AU8681698A (en) Imidazoquinoxaline protein tyrosine kinase inhibitors
AU7289696A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
FI960089A0 (en) Oligonucleotide modulation of protein kinase C.
HUP0103633A3 (en) Substituted 3-cyanoquinolines as protein tyrosine kinases inhib
AU6882598A (en) Protein kinase inhibitor
HUP0103079A3 (en) Modulating multiple lineage kinase proteins
AU7687998A (en) Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
AU6049399A (en) Serine/threonine protein kinases
AU8778698A (en) Serine/threonine kinase, and uses related thereto
ZA983669B (en) Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds.
AU6421498A (en) Serine/threonine protein kinase